ABD - İngilizce - NLM (National Library of Medicine)

greenstone llc - diphenoxylate hydrochloride (unii: w24od7yw48) (diphenoxylate - unii:73312p173g), atropine sulfate (unii: 03j5ze7ka5) (atropine - unii:7c0697dr9i) - diphenoxylate hydrochloride 2.5 mg - diphenoxylate hydrochloride and atropine sulfate is indicated as adjunctive therapy in the management of diarrhea in patients 13 years of age and older. diphenoxylate hydrochloride and atropine sulfate is contraindicated in: diphenoxylate hydrochloride and atropine sulfate is classified as a schedule v controlled substance by federal regulation. diphenoxylate hydrochloride is chemically related to the narcotic analgesic meperidine. in doses used for the treatment of diarrhea, whether acute or chronic, diphenoxylate has not produced addiction. diphenoxylate hydrochloride is devoid of morphine-like subjective effects at therapeutic doses. at high doses it exhibits codeine-like subjective effects. the dose which produces antidiarrheal action is widely separated from the dose which causes central nervous system effects. the insolubility of diphenoxylate hydrochloride in commonly available aqueous media precludes intravenous self-administration. a dose of 100 to 300 mg/day, which is equivalent to 40 to 120 tablets

ABD - İngilizce - NLM (National Library of Medicine)

general injectables and vaccines, inc - diphenhydramine hydrochloride (unii: tc2d6jad40) (diphenhydramine - unii:8gts82s83m) - diphenhydramine hydrochloride 50 mg in 1 ml - diphenhydramine hydrochloride in the injectable form is effective in adults and pedi­atric patients, other than premature infants and neonates, for the following conditions when diphenhydramine hydrochloride in the oral form is impractical. antihistaminic for amelioration of allergic reactions to blood  or plasma, in anaphylaxis as an adjunct to  epinephrine and other standard measures after the acute symptoms have been controlled, and for  other  uncomplicated allergic conditions  of the immediate type when oral therapy is impossible or contraindicated. motion sickness for active treatment of motion sickness. antiparkinsonism for use in parkinsonism, when oral therapy is impossible or contraindicated, as follows: parkinsonism in the elderly who are unable to tolerate more potent agents; mild  cases of  parkinsonism in other age groups, and in other  cases of parkinsonism in combination with  centrally acting anticholinergic agents.

ABD - İngilizce - NLM (National Library of Medicine)

pharmaceutical associates, inc. - diphenhydramine hydrochloride (unii: tc2d6jad40) (diphenhydramine - unii:8gts82s83m) - diphenhydramine hydrochloride 12.5 mg in 5 ml - diphenhydramine hydrochloride in the oral form is effective for the following indications: for allergic conjunctivitis due to foods; mild, uncomplicated allergic skin manifestations of urticaria and angioedema; amelioration of allergic reactions to blood or plasma; dermatographism; as therapy for anaphylactic reactions adjunctive to epinephrine and other standard measures after the acute manifestations have been controlled. for active and prophylactic treatment of motion sickness. for parkinsonism (including drug-induced) in the elderly unable to tolerate more potent agents; mild cases of parkinsonism (including drug-induced) in other age groups; in other cases of parkinsonism (including drug-induced) in combination with centrally acting anticholinergic agents. nighttime sleep-aid. this drug should not be used in neonates or premature infants. because of the h

ABD - İngilizce - NLM (National Library of Medicine)

physicians total care, inc. - diphenhydramine hydrochloride (unii: tc2d6jad40) (diphenhydramine - unii:8gts82s83m) - diphenhydramine hydrochloride 25 mg - - temporarily relieves these symptoms associated with the common cold, hay fever, or other respiratory allergies. - sneezing. - nasal congestion. - runny nose. - itchy, watery eyes. - with any other product containing diphenhydramine hcl, including one applied topically. - trouble urinating due to enlarged prostate gland - a breathing problem such as emphysema or chronic bronchitis - glaucoma - if you are taking sedatives or tranquilizers

ABD - İngilizce - NLM (National Library of Medicine)

lake erie medical dba quality care products llc - diphenoxylate hydrochloride (unii: w24od7yw48) (diphenoxylate - unii:73312p173g), atropine sulfate (unii: 03j5ze7ka5) (atropine - unii:7c0697dr9i) - diphenoxylate hydrochloride 2.5 mg - diphenoxylate hydrochloride is indicated as adjunctive therapy in the management of diarrhea in patients 13 years of age and older. diphenoxylate hydrochloride is contraindicated in: - pediatric patients less than 6 years of age due to the risks of respiratory and central nervous system (cns) depression (see warnings ). - patients with diarrhea associated with pseudomembranous enterocolitis (clostridium difficile ) or other enterotoxin-producing bacteria due to the risk of gastrointestinal (gi) complications, including sepsis (see warnings ). - patients with known hypersensitivity to diphenoxylate or atropine. - patients with obstructive jaundice. diphenoxylate hydrochloride is classified as a schedule v controlled substance by federal regulation. diphenoxylate hydrochloride is chemically related to the narcotic analgesic meperidine. in doses used for the treatment of diarrhea, whether acute or chronic, diphenoxylate has not produced addiction. diphenoxylate hydrochloride is devoid of morphine-like subjective

ABD - İngilizce - NLM (National Library of Medicine)

atlantic biologicals corps - diphenoxylate hydrochloride (unii: w24od7yw48) (diphenoxylate - unii:73312p173g), atropine sulfate (unii: 03j5ze7ka5) (atropine - unii:7c0697dr9i) - diphenoxylate hydrochloride 2.5 mg - diphenoxylate hydrochloride is effective as adjunctive therapy in the management of diarrhea. diphenoxylate hydrochloride is contraindicated in patients with: - known hypersensitivity to diphenoxylate or atropine. - obstructive jaundice. - diarrhea associated with pseudomembranous enterocolitis or enterotoxin-producing bacteria. diphenoxylate hydrochloride is classified as a schedule v controlled substance by federal regulation. diphenoxylate hydrochloride is chemically related to the narcotic analgesic meperidine. in doses used for the treatment of diarrhea, whether acute or chronic, diphenoxylate has not produced addiction. diphenoxylate hydrochloride is devoid of morphine-like subjective effects at therapeutic doses. at high doses it exhibits codeine-like subjective effects. the dose which produces antidiarrheal action is widely separated from the dose which causes central nervous system effects. the insolubility of diphenoxylate hydrochloride in commonly available aqueous media precludes intravenous self-

ABD - İngilizce - NLM (National Library of Medicine)

physicians total care, inc. - diphenhydramine hydrochloride (unii: tc2d6jad40) (diphenhydramine - unii:8gts82s83m) - diphenhydramine hydrochloride 50 mg - antihistamine temporarily relieves these symptoms due to hay fever or other upper respiratory allergies - runny nose and sneezing - itching of the nose or throat - itchy, watery eyes.

ABD - İngilizce - NLM (National Library of Medicine)

atlantic biologicals corps - diphenoxylate hydrochloride (unii: w24od7yw48) (diphenoxylate - unii:73312p173g), atropine sulfate (unii: 03j5ze7ka5) (atropine - unii:7c0697dr9i) - diphenoxylate hydrochloride 2.5 mg in 5 ml - diphenoxylate hydrochloride and atropine sulfate is effective as adjunctive therapy in the management of diarrhea. diphenoxylate hydrochloride and atropine sulfate is contraindicated in patients with: diphenoxylate hydrochloride and atropine sulfate oral solution is classified as a schedule v controlled substance by federal regulation. diphenoxylate hydrochloride is chemically related to the narcotic analgesic meperidine. in doses used for the treatment of diarrhea, whether acute or chronic, diphenoxylate has not produced addiction. diphenoxylate hydrochloride is devoid of morphine-like subjective effects at therapeutic doses. at high doses it exhibits codeine-like subjective effects. the dose which produces antidiarrheal action is widely separated from the dose which causes central nervous system effects. the insolubility of diphenoxylate hydrochloride in commonly available aqueous media precludes intravenous self-administration. a dose of 100 to 300 mg/day, which is equivalent to 40 to 120 tablets, administ

ABD - İngilizce - NLM (National Library of Medicine)

bryant ranch prepack - diphenoxylate hydrochloride (unii: w24od7yw48) (diphenoxylate - unii:73312p173g) - diphenoxylate hydrochloride 2.5 mg

ABD - İngilizce - NLM (National Library of Medicine)

unit dose services - diphenoxylate hydrochloride (unii: w24od7yw48) (diphenoxylate - unii:73312p173g) - diphenoxylate hydrochloride 2.5 mg